Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFA112059: Fluticasone furoate inhalation powder in persistent asthma
2010-020144-34Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone in asthma (3 arms), sponsored by GSK. Started Aug 2010; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-020144-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020144-34.